INFECTION WITH HEPATITIS VIRUSES (B AND C) AND HUMAN RETROVIRUSES (HTLV-1 AND HIV) IN SAUDI CHILDREN RECEIVING CYCLED CANCER-CHEMOTHERAPY

被引:7
作者
BAKIR, TMF [1 ]
KURBAAN, KM [1 ]
ALFAWAZ, I [1 ]
RAMIA, S [1 ]
机构
[1] KING SAUD UNIV,COLL MED,DEPT PEDIAT,RIYADH 11461,SAUDI ARABIA
关键词
D O I
10.1093/tropej/41.4.206
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Serological markers of hepatitis B virus (HBV), hepatitis C virus (HCV), human T-cell lymphotropic virus type 1 (HTLV-1), acid human immunodeficiency viruses (HIV-1 and HIV-2) were studied in 53 Saudi children (31 males, 22 females; 1-12 years of age) receiving cycled cancer chemotherapy and in 168 healthy Saudi children taken as control. Exposure to HBV in the patients was similar to that in the control (6 per cent HBsAg in patients v. 7 per cent in the control; 19 per cent exposure rate in patients v. 20 per cent in control). None of our patients was vaccinated against HBV prior to chemotherapy. The fact that among the 10 HBV exposed patients five patients were anti-HBs-positive is in favour of vaccinating Saudi oncology patients against HBV prior to chemotherapy. In contrast to the situation with HBV the prevalence of anti-HCV in the patients (11 per cent) was significantly higher than that in the control (1 per cent) (P = 0.003). None of our patients or the control were anti-HTLV-1 or anti-HIV-positive. The results of this study stress the need for an awareness of HCV problem in Saudi oncology patients. Strict measures of screening blood donors for all blood-borne viruses and, in particular, for HCV in addition to the use of disposable equipment in management of cancer patients are items that should be implemented as soon as possible.
引用
收藏
页码:206 / 209
页数:4
相关论文
共 30 条
[1]  
Al-Nozha M. M., 1987, AIDS-Forschung, V2, P508
[2]  
ALNASSER MN, 1992, VOX SANG, V62, P94
[3]   HEPATITIS-C VIRUS-ANTIBODIES IN HIGH-RISK SAUDI GROUPS [J].
BAHAKIM, H ;
BAKIR, TMF ;
ARIF, M ;
RAMIA, S .
VOX SANGUINIS, 1991, 60 (03) :162-164
[4]   A 7-YEAR SURVEY OF ACUTE HEPATITIS TYPE-B [J].
BORTOLOTTI, F ;
CADROBBI, P ;
BERTAGGIA, A ;
RUDE, L ;
ALBERTI, A ;
REALDI, G .
ARCHIVES OF DISEASE IN CHILDHOOD, 1983, 58 (12) :993-996
[5]   ISOLATION OF A CDNA CLONE DERIVED FROM A BLOOD-BORNE NON-A, NON-B VIRAL-HEPATITIS GENOME [J].
CHOO, QL ;
KUO, G ;
WEINER, AJ ;
OVERBY, LR ;
BRADLEY, DW ;
HOUGHTON, M .
SCIENCE, 1989, 244 (4902) :359-362
[6]   IMMUNOPATHOLOGICAL MECHANISMS OF LIVER-CELL INJURY IN CHRONIC HEPATITIS-B VIRUS-INFECTION [J].
EDDLESTON, ALWF ;
MONDELLI, M .
JOURNAL OF HEPATOLOGY, 1986, 3 :S17-S23
[7]   RECURRENCE OF HEPATITIS-B IN CHILDREN WITH SEROLOGIC EVIDENCE OF PAST HEPATITIS-B VIRUS-INFECTION UNDERGOING ANTILEUKEMIC CHEMOTHERAPY [J].
GRUMAYER, ER ;
PANZER, S ;
FERENCI, P ;
GADNER, H .
JOURNAL OF HEPATOLOGY, 1989, 8 (02) :232-235
[8]   LEUKEMIA AND LIVER-DISEASE IN CHILDHOOD - CLINICAL AND HISTOLOGICAL-EVALUATION [J].
GUIDO, M ;
ROSSETTI, F ;
RUGGE, M ;
CESARO, S ;
ANELONI, V ;
NINFO, V ;
ZANESCO, L .
TUMORI, 1991, 77 (04) :319-322
[9]   LONG-TERM FOLLOW-UP OF POSTTRANSFUSION AND SPORADIC CHRONIC HEPATITIS NON-A, NON-B AND FREQUENCY OF CIRCULATING ANTIBODIES TO HEPATITIS-C VIRUS (HCV) [J].
HOPF, U ;
MOLLER, B ;
KUTHER, D ;
STEMEROWICZ, R ;
LOBECK, H ;
LUDTKEHANDJERY, A ;
WALTER, E ;
BLUM, HE ;
ROGGENDORF, M ;
DEINHARDT, F .
JOURNAL OF HEPATOLOGY, 1990, 10 (01) :69-76
[10]   FULMINANT HEPATITIS-C VIRAL-INFECTION AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION [J].
KANAMORI, H ;
FUKAWA, H ;
MARUTA, A ;
HARANO, H ;
KODAMA, F ;
MATSUZAKI, M ;
MIYASHITA, H ;
MOTOMURA, S ;
OKUBO, T ;
YOSHIBA, M ;
SEKIYAMA, K .
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1992, 303 (02) :109-111